510(k) Report

510(k) · Cleared

Cleared

Nasopore Nasal Dressing, Model Ndox-Yyy/ZZ

K052099510(k) TraditionalCleared Nov 21, 2005110-day reviewClass I21 CFR 874.4780

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Polyganics B.V., · LYA Splint, Intranasal Septal

Cleared on Nov 21, 2005 as substantially equivalent to K012532 (Genzyme Corp., 2001) and 2 other predicates after a 110-day review. Its family tree reaches back 2 generations to 1997. 17 later devices descend from it.

Decided
Nov 21, 2005
Review
110 days
Class
Class I
Product code
LYA
Recalls
None
Predicates
3

Its longest line of descent runs back 2 generations to K972082 (1997). 5 ancestors in all. 17 later devices descend from it, 10 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2004: 1 other ancestor1999: 1 other ancestor2001: 1 other ancestor2014: 4 descendants cleared2012: 1 descendant cleared2007: 1 descendant cleared2020: 1 descendant cleared2006: 1 descendant cleared2008: 1 descendant cleared2016: 1 descendant cleared2009: 1 descendant cleared2022: 1 descendant cleared2017: 2 descendants cleared2013: 1 descendant cleared2018: 1 descendant cleared2023: 1 descendant clearedK972082 · Custom Nasal Splint · Boston Medical Products, Inc. · 1997K012532 · Sepragel Sinus · Genzyme Corp. · 20011995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors2 generations back: 1 other ancestor 1 generation forward: 10 descendants2 generations forward: 4 descendants3 generations forward: 2 descendants4 generations forward: 1 descendant K012532 · Sepragel Sinus · Genzyme Corp. · 2001K972082 · Custom Nasal Splint · Boston Medical Products, Inc. · 19970
  1. Root · 2 generations backK972082 Custom Nasal SplintBoston Medical Products, Inc. · 1997
  2. 1 generation backK012532 Sepragel SinusGenzyme Corp. · 2001
  3. This deviceK052099 Nasopore Nasal Dressing, Model Ndox-Yyy/ZZPolyganics B.V., · 2005
  4. Descendant · cites it directly · 7 of its ownK113585 Nasal/Epistaxis PackCogent Therapeutics, LLC · 2012
  5. Descendant · cites it directly · 3 of its ownK082276 Synthemed DeviceSynthemed, Inc. · 2008
  6. Descendant · 2 generations on · 2 of its ownK141704 Novashield Injectable Nasal Packing and StentMedtronic, Inc. · 2014
  7. Descendant · 2 generations on · 2 of its ownK122494 Posisep and Posisep X Hemostat Dressing/Intranasal SplintHemostasis, LLC · 2013
  8. Descendant · 3 generations on · 1 of its ownK172179 Chitogel Endoscopic Sinus Surgery KitChitogel, Ltd. · 2017

Showing 5 of 17 descendants. See all descendants

Descendants cleared per year

2006: 12007: 12008: 12009: 12012: 12013: 12014: 42016: 12017: 22018: 12020: 12022: 12023: 1
2006high 4 (2014) · low 0 (2010)2026

Most influential descendants

Showing 5 of 17 · See all
  • K113585Nasal/Epistaxis PackCogent Therapeutics, LLC · 2012 · cites it directly7descendants
  • K082276Synthemed DeviceSynthemed, Inc. · 2008 · cites it directly3descendants
  • K141704Novashield Injectable Nasal Packing and StentMedtronic, Inc. · 2014 · 2 generations on2descendants
  • K122494Posisep and Posisep X Hemostat Dressing/Intranasal SplintHemostasis, LLC · 2013 · 2 generations on2descendants
  • K172179Chitogel Endoscopic Sinus Surgery KitChitogel, Ltd. · 2017 · 3 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K972082Custom Nasal SplintBoston Medical Products, Inc.1997—
−1K012532Sepragel SinusGenzyme Corp.2001—
0 (this device)K052099Nasopore Nasal Dressing, Model Ndox-Yyy/ZZPolyganics B.V.,2005—
+1K113585Nasal/Epistaxis PackCogent Therapeutics, LLC2012—
+1K082276Synthemed DeviceSynthemed, Inc.2008—
+2K141704Novashield Injectable Nasal Packing and StentMedtronic, Inc.2014—
+2K122494Posisep and Posisep X Hemostat Dressing/Intranasal SplintHemostasis, LLC2013—
+3K172179Chitogel Endoscopic Sinus Surgery KitChitogel, Ltd.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200110
200410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
200710
200810
200910
201210
201310
201440
201610
201720
201810
202010
202210
202310
FIG. 1 — Lineage of K052099, 1997–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LYA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LYA device

  1. #1 K243655 TurbAlignscore 10.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K012532Sepragel Sinus
Summary page 1
…lassification Name: Intranasal Splint, 21 CFR 874.4780 Device Classification: Class I Predicate - Seprapack/Sepragel; Genzyme; K01 2532 Devices: - Merogel Tm nasal dressing; Xomed; K982731 - MeropackTm nasal dressing…
Genzyme Corp.2001—
*K982731Merogel Nasal Dressing and Sinus Stent
Summary page 1
…Device Classification: Class I Predicate - Seprapack/Sepragel; Genzyme; K01 2532 Devices: - Merogel Tm nasal dressing; Xomed; K982731 - MeropackTm nasal dressing; Medtronic Xomned; K041381 Performance For the Nasopore perfo…
Xomed, Inc.1999—
*K041381Meropack Bioresorbable Nasal Packing and Sinus Stent
Summary page 1
…l; Genzyme; K01 2532 Devices: - Merogel Tm nasal dressing; Xomed; K982731 - MeropackTm nasal dressing; Medtronic Xomned; K041381 Performance For the Nasopore performance, the FDA, under section 514 of the Food, Drug Standards and Cosmet…
Medtronic Xomed, Inc.2004—

Also cleared against K012532: 5 other devices →

What descends from it? (17)

See all 17

10 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K113585Nasal/Epistaxis PackCogent Therapeutics, LLC20127
K082276Synthemed DeviceSynthemed, Inc.20083
K092401Sinexus Sinus Stent Gen 2, Model 1999-25Sinexus, Inc.20091
K070715Nasopore EarPolyganics B.V.,20071
K202623Novapak Nasal Sinus Packing and StentMedtronic Xomed20200
K160101SinuBandBioinspire Technologies, Incorporated20160
K141816HemoporePolyganics B.V.,20140
K141423Nasopore-FDPolyganics B.V.,20140
K140992Arthrocare Nasastent CMC Nasal DressingArthroCare Corporation20140
K062540Nasopore Ear, Models ND04, ND05Polyganics B.V.,20060

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 8 years and passes through 3 companies; a new generation was cleared every 4.3 years on median.
  • None of the 5 ancestors has a recall.
  • Of its descendants, K113585 (Cogent Therapeutics, LLC, 2012) has gone furthest, with 7 descendants of its own.
  • 5 other devices also cite its predicate K012532.

How does its category compare?

All LYA devices

LYA Splint, Intranasal Septal: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LYA

1in 2025

2007: 12008: 22009: 12012: 12013: 22014: 52016: 12017: 22018: 22020: 12021: 12023: 12025: 1
2007high 5 (2014) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LYA

104in 2014

2014: 104 days median
2007high 104 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LYA

No recall names LYA since 2007.

Adverse event reports per year · LYA

1in 2025

2007: 22009: 52010: 22011: 162012: 162013: 12014: 42015: 282016: 282017: 102018: 192019: 52020: 62021: 192022: 82023: 172024: 72025: 1
2007high 28 (2015) · low 0 (2008)2025

MAUDE reports naming product code LYA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—02
20082—00
20091—05
20100—02
20110—016
20121—016
20132—01
2014510404
20150—028
20161—028
20172—010
20182—019
20190—05
20201—06
20211—019
20220—08
20231—017
20240—07
20251—01
20260—0—

What is it indicated for?

Nasopore® nasal dressing is a fragmentable nasal dressing and is indicated for use in patients undergoing nasal/sinus surgery as a space occupying stent to separate and prevent adhesions between mucosal surfaces; to help control minimal bleeding following surgery or nasal trauma by tamponade effect and blood absorption.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K052099: Nasopore Nasal Dressing, Model Ndox-Yyy/ZZ.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K052099

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026